Frank J. Ryan

This profile gathers the share dealings of Frank J. Ryan across 2 companies, led by Digene Corp and Interpace Biosciences, Inc. Between 6 June 2006 and 31 May 2011, the trades on record add up to 14 filings.

Purchases make up the whole of the open-market record (1 purchase, €19k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 6 share grants and 5 option exercises.

The record was last updated on 2 June 2011 with a share grant (€31k) in Interpace Biosciences, Inc. The most recent open-market purchase was published on 1 December 2008, 6,536 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.